BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24684413)

  • 1. Pediatric subcutaneous panniculitis-like T-cell lymphoma with favorable result by immunosuppressive therapy: a report of two cases.
    Nagai K; Nakano N; Iwai T; Iwai A; Tauchi H; Ohshima K; Ishii E
    Pediatr Hematol Oncol; 2014 Sep; 31(6):528-33. PubMed ID: 24684413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presenting manifestations of subcutaneous panniculitis-like T-cell lymphoma and T-cell lymphoma and cutaneous γδ T-cell lymphoma may mimic those of rheumatic diseases: a report of 11 cases.
    Yi L; Qun S; Wenjie Z; Wen Z; Jian L; Yan Z; Fengchun Z
    Clin Rheumatol; 2013 Aug; 32(8):1169-75. PubMed ID: 23588884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Panniculitis-Like T-Cell Lymphoma in Children: A Review of the Literature.
    Hu ZL; Sang H; Deng L; Li Z
    Pediatr Dermatol; 2015; 32(4):526-32. PubMed ID: 25727090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous panniculitis-like T cell lymphoma presented as erythema nodosum: A case report.
    Sun D; Zheng S; Hong YX; Chen HD; Gao XH
    Dermatol Ther; 2021 Jan; 34(1):e14572. PubMed ID: 33219732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic, immunophenotypic, and molecular analysis of subcutaneous panniculitis-like T-cell lymphoma: A retrospective study in a tertiary care center.
    Rutnin S; Porntharukcharoen S; Boonsakan P
    J Cutan Pathol; 2019 Jan; 46(1):44-51. PubMed ID: 30350476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Comparative Analysis of Lupus Panniculitis and Subcutaneous Panniculitis-like T-cell Lymphoma].
    Wen PF; Zhou QT; Wan C; Liu XY; Xie Y; Li F; Wang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):930-934. PubMed ID: 31880127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoatrophic panniculitis of the ankles in childhood: differential diagnosis with subcutaneous panniculitis-like T-cell lymphoma.
    Santonja C; Gonzalo I; Feito M; Beato-Merino M; Requena L
    Am J Dermatopathol; 2012 May; 34(3):295-300. PubMed ID: 22513806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fever and generalized erythema caused by subcutaneous panniculitis-like T-cell lymphoma.
    Kondo T; Uehara T; Suzuki S; Noda K; Ohira Y; Ikusaka M
    Pol Arch Med Wewn; 2015; 125(11):867-8. PubMed ID: 26621148
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous panniculitis-like T-cell lymphoma responsive to combination therapy with methotrexate and corticosteroids.
    Grinich E; Koon SM; Cascio MJ; Fett N
    Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous panniculitis-like T-cell lymphoma in type 1 neurofibromatosis: a case report.
    Reich A; Butrym A; Mazur G; Tubek S; Wąsik G; Brzezicha B; Woźniak Z
    Acta Dermatovenerol Croat; 2014; 22(2):145-9. PubMed ID: 25102802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic significance of immunophenotyping and detection of gene rearrangement in subcutaneous panniculitis-like T-cell lymphoma].
    Wan C; Xu C; Wang L; Li GD; Jiang W; Zhang WY; Tang Y; Kan B; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):390-4. PubMed ID: 19031718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy.
    Michonneau D; Petrella T; Ortonne N; Ingen-Housz-Oro S; Franck N; Barete S; Battistella M; Beylot-Barry M; Vergier B; Maynadié M; Bodemer C; Hermine O; Bagot M; Brousse N; Fraitag S
    Acta Derm Venereol; 2017 Mar; 97(3):358-364. PubMed ID: 27722764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobular panniculitis due to Borrelia burgdorferi infection mimicking subcutaneous panniculitis-like T-cell lymphoma.
    Kempf W; Kazakov DV; Kutzner H
    Am J Dermatopathol; 2013 Apr; 35(2):e30-3. PubMed ID: 23038025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous panniculitis-like T-cell lymphoma in a 26-month-old child with a review of the literature.
    Yim JH; Kim MY; Kim HO; Cho B; Chung NG; Park YM
    Pediatr Dermatol; 2006; 23(6):537-40. PubMed ID: 17155994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in subcutaneous panniculitis-like T-cell lymphoma.
    Rodriguez VR; Joshi A; Peng F; Rabah RM; Stockmann PT; Savaşan S
    Pediatr Blood Cancer; 2009 Mar; 52(3):406-8. PubMed ID: 18985722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous panniculitis-like T-cell lymphoma: successful treatment with systemic steroid alone.
    Jang MS; Baek JW; Kang DY; Kang JS; Suh KS; Kim ST
    J Dermatol; 2012 Jan; 39(1):96-9. PubMed ID: 22032642
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine.
    Go RS; Gazelka H; Hogan JD; Wester SM
    Ann Hematol; 2003 Apr; 82(4):247-50. PubMed ID: 12707730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subcutaneous panniculitis-like T-cell lymphoma: The authors' experience of diagnosis and treatment].
    Gorodetskiy VR; Probatova NA; Vasilyev VI; Mukhortova OV; Aslanidi IP; Sidorova YV; Ryzhikova NV; Radenska-Lopovok SG; Egorova ON
    Ter Arkh; 2016; 88(7):49-55. PubMed ID: 27459615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not all swellings are lymph nodes! A case of subcutaneous panniculitis-like T-cell lymphoma.
    Tee Evelyn Wy Yap CT; Evelyn Yap WY
    Med J Malaysia; 2019 Oct; 74(5):441-442. PubMed ID: 31649225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.